Latest News for: nanoscope

Edit

Nanoscope Therapeutics Announces Participation at Eyecelerator® and ARVO 2026 Annual Meetings

PR Newswire 23 Apr 2026
Presentations to highlight Nanoscope's best-in-class efficacy, durability, and safety ofoptogenetic therapy platforms ... Nanoscope team members will be available at Booth 6065 for the duration of the ARVO conference ... SOURCE Nanoscope Therapeutics.
Edit

Nanoscope Therapeutics Appoints Ophthalmology Industry Veteran Paul Hallen as Chief Operating Officer to Advance Global Commercial Readiness

PR Newswire 01 Apr 2026
Appointment strengthens operational leadership as Nanoscope advances MCO-010 (MOGENRY™) toward BLA submission and potential commercialization ... Contact.Nanoscope Therapeutics, Inc.+1 (817) 857-1186[email protected]. SOURCE Nanoscope Therapeutics.
Edit

Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership ...

Globe Gazette 31 Mar 2026
DALLAS, March 30, 2026 /PRNewswire/ -- Nanoscope ...
Edit

Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership in Vision Restoration

PR Newswire 30 Mar 2026
About Nanoscope Therapeutics Nanoscope Therapeutics is developing a disease-agnostic, vision-restoring optogenetic therapy for millions of patients blinded by retinal degenerative diseases ... SOURCE Nanoscope Therapeutics.
Edit

Nanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease

Herald & Review - Decatur 24 Mar 2026
DALLAS, March 23, 2026 /PRNewswire/ -- Nanoscope Therapeutics, ...
Edit

Nanoscope Therapeutics Post-Hoc Clinical Analyses to be Presented at 2026 Macula Society Annual Meeting

Sweetwater Reporter 25 Feb 2026
Dr. Christine N. Kay to Present Multivariant Analysis of 3-Year RESTORE and REMAIN Data, Identifying Patient and Disease Characteristics Associated with Best Outcomes in Retinitis Pigmentosa Patients Following MCO-010 Optogenetic Gene Therapy ....
Edit

The Longevity Centers of America Introduces Minimally Invasive NanoScope Needle Arthroscopy for Joint Pain Relief

ACCESSWIRE 29 Jan 2026
WEST PALM BEACH, FLORIDA / ACCESS Newswire / January 29, 2026 / The Longevity Centers of America (LCOA) has expanded its regenerative medicine capabilities with the introduction of NanoScope Needle Arthroscopy.
Edit

Nanoscopic raft dynamics on cell membranes successfully visualized for first time

Phys Dot Org 20 Jan 2026
....
Edit

Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A ...

Citizen Tribune 20 Jan 2026
Japan's Ministry of Health, Labor and Welfare (MHLW) grants ...
Edit

Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A First for a Retinal Gene Therapy

PR Newswire 20 Jan 2026
"These designations from Japan's MHLW mark another pivotal milestone for Nanoscope," said Samarendra Mohanty, PhD, President, and Chief Scientific Officer of Nanoscope Therapeutics ... SOURCE Nanoscope Therapeutics.
  • 1

Article Search

tools
×
×
×
×